Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity
Yi Yang1, Siqi Wang2, Jiaoyang Cai2, Liang Jiang2, Yingwen Zhang1, Yangyang Xie2, Fei Luo3, Jingjing Tang2, Yijin Gao4, Shuhong Shen4, Haizhong Feng5, Yanxin Li6
1Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children?s Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.
2Department of Hematology & Oncology, Shanghai Children?s Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.
3State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
4Department of Hematology & Oncology, Shanghai Children?s Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, China
5State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
6Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children?s Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, China
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Springer Science and Business Media LLC
Tập 46 Số 6
1871-1872
Thông tin tác giả